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The conceptualization of immunological self is amongst the most important theories of
modern biology, representing a sort of theoretical guideline for experimental immunolo-
gists, in order to understand how host constituents are ignored by the immune system (IS).
A consistent advancement in this field has been represented by the danger/damage theory
and its subsequent refinements, which at present represents the most comprehensive con-
ceptualization of immunological self. Here, we present the new hypothesis of “liquid self,”
which integrates and extends the danger/damage theory.The main novelty of the liquid self
hypothesis lies in the full integration of the immune response mechanisms into the host
body’s ecosystems, i.e., in adding the temporal, as well as the geographical/evolutionary
and environmental, dimensions, which we suggested to call “immunological biography.”
Our hypothesis takes into account the important biological changes occurring with time
(age) in the IS (including immunosenescence and inflammaging), as well as changes in the
organismal context related to nutrition, lifestyle, and geography (populations).We argue that
such temporal and geographical dimensions impinge upon, and continuously reshape, the
antigenicity of physical entities (molecules, cells, bacteria, viruses), making them switching
between “self” and “non-self” states in a dynamical, “liquid” fashion. Particular attention
is devoted to oral tolerance and gut microbiota, as well as to a new potential source of
unexpected self epitopes produced by proteasome splicing. Finally, our framework allows
the set up of a variety of testable predictions, the most straightforward suggesting that the
immune responses to defined molecules representing potentials antigens will be quanti-
tatively and qualitatively quite different according to the immuno-biographical background
of the host.
Keywords: self, non-self, antigen presentation, gutmicrobiota, host–pathogen interaction,N -glycan, oral tolerance,
proteasome splicing
INTRODUCTION
In its historical development, the conceptualization of the immune
self has always suffered of an “ontological obsession” (Box 1). Self
had been focused on physical entities that Burnet identified as B
lymphocytes (i.e., cells) (1, 2) and, later on, Janeway and Matzinger
identified as pathogen-associated molecular patterns (PAMPs)
Abbreviations: DAMP, damage-associated molecular patterns; DCs, dendritic
cells; ER, endoplasmic reticulum; FoxP3, forkhead box P3; GALT, gut-associated
lymphoid tissue; IS, immune system; Ig, immunoglobulin; IFN, interferon; MHC,
major histocompatibility complex; PAMP, pathogen-associated molecular pat-
terns; PCPS, proteasome-catalyzed peptide splicing; Treg, regulatory T cells; SNS,
self/non-self; TCR, T cell-antigen receptor; Th, T helper cells; TGF-β, transforming
growth factor-β.
(3, 4) and danger signals (endogenous, non-foreign damage/alarm
signaling molecules) (5, 6), respectively (Box 2).
While playing a fundamental role in the development of the
immunological thinking, and because of its lack of sufficient
explanatory power of emergent phenomena such as inflammatory
and autoimmune diseases (36), the concept of immunological self
has nowadays revealed its main limits in excluding the host’s spa-
tial (i.e., geographical and environmental) and temporal (phylo-
and ontogenetic) dimensions. Indeed, according to the currently
recognized theories, the IS seems to be suspended in a limbo with-
out time and space. Our hypothesis here aims to instantiate that
the immune responses triggering is also intimately linked to host’s
spatial and temporal dimensions, which we will mainly refer to as
the so-called host’s immunological biography (37).
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Box 1 Rise, triumph, and decline of immune self.
As an implicit concept, the notion of “biological individuality” raised in the second half of the nineteenth century (7). Bernard’s milieu
intérieure (internal environment) as a prerequisite of life itself and Virchow’s cellular ability to preserve the identity against external attacks
represent two examples of an auroral phase in which the dichotomy between the organisms’ individuality and their environment began to
be introduced in the biological thought. Along these lines, Metchnikoff and Ehrlich gave a pivotal contribution in underpinning the “biological
individuality” on specific immunological level, the former by proposing cell theory of phagocytosis as a pathogen-engulfing mechanism able
to maintain organismal identity (7), the latter by suggesting the concept of “horror autotoxicus” to explain how immune system (IS) avoids
toxic reactions against the endogenous constituents.
Seminal investigations were later on advanced by Loeb upon “the biological basis of individuality,” which in 1927 explicitly questioned
the biochemical dynamics of graft rejection in different individuals (8), and in 1945 discussed individual specificity as a consequence of
relationships among genes, enzymes, and blood groups, also including psychological and social dimension (9). However, the first scientist
to put forth a purely immunological concept of selfhood, so as to become the theoretical backbone of the discipline, was the Australian
immunologist Frank M. Burnet in 1949. Linked to the notion of “tolerance,” the “immunological self” initially advanced by Burnet coincided
with all cell surface pattern recognitions that are ignored by the normal immune defensive action, namely the biological constituents peculiar
to each individual (2). With the beginning of the 1960s, the notion of self became the pivotal concept of Burnet’s clonal selection theory, a
new model which states that a randomly diversified population of clones – and not, as previously thought, a single adaptable antibody – was
responsible of selecting the antigen, put the entire immunology on the right Darwinian track after almost half a century of Lamarckian
approaches. The SNS paradigm was indeed coeval with the entry of immunology in the mainstream of the dominant Darwinian disciplines
like genetics and paleontology involved in the Modern Evolutionary Synthesis, a conceptual frame that led many dispersed biological fields
to a common selective paradigm during the 1930s and 1940s. In the subsequent two decades (1960–1980), the theory of “self–non-self”
(SNS) has enjoyed a large and growing credit amongst immunologists, imparting a new impetus to the entire discipline.
Also, it offered an immediate theoretical framework to novel outcomes such as the idea of “immunological surveillance” of tumors, the
early experimental successes of tissue transplantation tolerance, and the discovery that T cell recognition depended on the restriction of
major histocompatibility complex (MHC) coded by human leukocyte antigen (HLA) genes (10).
In the early 1980s, several experimental data confirmed that the IS may not only sometimes fail to mount the expected immune response
against foreign material (non-self elements), but, as in the case of autoimmune diseases, it also directs its activity against autologous mate-
rials (self elements). In this new scenario, SNS discrimination began to be seen as a useless or erroneous theory and its progressive
debunking can be summarized in three phases.
Phase I: Represented by isolated attempts, the first phase coincided with the discovery of “clonal anergy,” which demonstrated that
in immature mammals some self-reactive B cells might survive in a dormant (anergic) state, potentially becoming clones tolerant toward
non-self elements in adulthood (11). Further criticisms arrived from the reappraisal of induced oral tolerance, which challenged the idea of a
stable immune self in mature mammals (12). An offensive also mounted on a pure theoretical level, when in the mid 1970s, the influential
Niels Jerne’s idiotypic network theory first suggested a selfless hypothesis to explain the whole immune activity: any concept of foreignness
(and of selfhood) was in fact excluded in this theory, which stated that any antibody might be directed to either external antigens or body’s
constituents.
Phase II: A second phase arrived with the post-self “costimulatory” models, which attempted to reconcile SNS theory with the chronic
production of auto-reactive molecules. Proposed between the 1970s and the 1980s, the first step was took by Bretscher and Cohn’s two-
signal model, which described the necessity of a “help” signal and a cellular co-stimulation to induce the mechanism of SNS discrimination
in the elimination of self-reactive B cells (13). Inspired by this first attempt, Lafferty and Cunningham’s two-signal model further introduced
a new “accessory cell,” i.e., the antigen-presenting cell (APC) and a new costimulatory signal to support T helper (Th) lymphocytes in
evaluating the actual foreignness of the antigenic molecules (14); Janeway’s infectious-non-self model finally suggested that in the antigen
recognition process some “costimulatory cells,” endowed with a quiescent ability to distinguish between “infectious non-self” and “non-
infectious self,” were triggered by a chain of signals whereby a set of germ line-encoded pattern recognition receptors (PRRs) recognizes
conserved PAMPs on bacteria (3, 4).
Phase III: A third phase began at the turn of the 1990s with the proposal by Coutinho, Cohen, Cunliffe, Dembic, and Matzinger of the
post-self theoretical models. As a main proponent of the “second generation” of the Jernian network theorists (also called Paris School) (15),
Coutinho advanced the idea that autoimmunity should be considered a normal physiological function – an “active-resting” state detectable
with general patterns of collective, low-titer (auto-)antibody reactivities (16, 17) – being the IS activity twofold: a central network devoted to
regulate itself with itself, collecting auto-reactive and connected lymphocytes and serving as a host-monitoring system, as well as a periph-
eral network made by disconnected clones, bereft of auto-reactive cells, ready to be triggered by foreign antigen (18, 19).With the hypothesis
of “immunological homunculus,” also Cohen integrated, insomuch as to become a physiological function, the autoimmune response (20,
21). Here, rather than replaced, the Burnettian theory of self is overturned for the autoimmunity and the constant surveillance of non-self
elements becomes a regular activity of a self-monitoring IS to maintain an internal equilibrium. The idea to abandon the mechanism of
self–non-self discrimination in favor of a “morphostasis” process governing the tissues’ disorganization (cytokines-burst) was advanced by
Cunliffe (22) and then significantly re-elaborated by Dembic (23, 24) with the “integrity hypothesis,” which proposes three groups of signals
coordinating immunocytes and dendritic cells actions. As the most critical immunologist against the SNS theory, Matzinger’s danger model
suggested that to activate an appropriate immune response, the APCs need to be co-stimulated by “endogenous, non-foreign danger/alarm
signals,” provided by the surrounding environment in presence of stressed, damaged, or infected cells (5).This model specifically suggested
a cellular process in which the discriminatory concept of “foreignness” of the constituents is no longer the condition for the activation of
the immune response (e.g., mother/fetus relationship), as well as “immunological identity” of the host tissue is no longer a guarantee of
tolerance (e.g., cell mutation or cancer).
(Continued)
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Box 1 Continued
Notwithstanding its originality, which mainly consists in reorienting the activity of IS as concerned with entities that do damage rather than
with those that are foreign, the danger model appears to be still focused on a materialistic view and a undefined temporal dimension. On
one hand, Matzinger’s theory, in a way similar to costimulatory models, points to the materiality of signals, just suggesting a shift from
non-self signals (emanated by “anything that is foreign or new”) to danger/damage signals (emanated by “anything that induces stress or
non-physiological death of a cell”). Along these lines, the danger model improves the classic discriminatory concept of aggression/tolerance
by adding further “endogenous” signals such as pathogens, environmental toxins or mutations that lead to stress or inappropriate cell death
or inefficient scavenging. On the other, such a theory offers no insight on geographical and population contexts, offering only a brief look
at the different ontogenetic phases of the host. In this theory, as well as in all the previous ones, the temporal/biographical dimension is
unsatisfactorily represented (25). The various parameters that will change with time should be, on the contrary, considered inevitable and
intrinsic in the IS dynamics.
From danger model back to Burnet conceptualization, all the variants of immunological self advanced insofar have been focused on
“materialistic” (cellular or molecular) signals able to trigger the immune response. We think that a step forward could be taken by also
considering the “procedural” (time and space-related) aspect, rather than a materialistic one, of the immune response.
Even the most modern conceptualization about immune
response triggering, and namely the Matzinger’s danger theory
(5, 6), shows problematic issues in several key points. In this par-
ticular aspect, other authors argue that the concept of “danger”
is a theoretical suggestion, while, conversely, the idea of molecu-
lar “damage” signals has led to a number of experimental studies
especially focused on endogenous damage, which is where the
innovation of the danger theory lies (38). Several drawbacks (e.g.,
insufficient explanations of innate immunity and response to sym-
biotic bacteria, among others) afflict the danger theory that may
finally prove to be not completely satisfying (36).
To overcome such limitations, here we propose a wider frame-
work for the immune response triggering in which we hypothesize
that: (1) the (definition of the) self is a process, an evolving config-
uration of states, and should not be strictly referred to a physical
entity (ontology); (2) as a process, the self is dynamic because
it varies depending on the internal (inflammatory, mostly) and
external (ecological) contexts; (3) the self is mainly defined within
a continuum of states by the immunological history at the species
(evolutionary) and the individual (ontogenetic) level, i.e., by the
quantitative, qualitative, and temporal aspects of the immunolog-
ical stimuli that each of us is exposed to in our lifelong history. In
particular, besides structure, dose, time, and localization of antigen
(39), we underline the importance of the host’s temporal dimen-
sion in terms of antigen exposure in utero (40), during birth (41),
and in senescence (42).
As a consequence, the old question whether a given mole-
cule belongs to self or non-self looses its significance as it largely
depends on the context (43), which will be here referred to as the
wider perspective of the immunological biography (37).
Accordingly, by recovering the widely used sociologic metaphor
advanced by Zigmunt Bauman to indicate amorphous, elusive,
and rapidly changing values of contemporary Western societies
(44, 45), we propose to make the final step from an ontolog-
ical and static idea of self to a, context-, spatial-, temporal-,
inflammatory-, and finally process-dependent concept, and thus
introduce the hypothesis of liquid self.
We will discuss our hypothesis by testing it on some of the most
forefront and fundamental immunological research areas, i.e., the
gut microbiota–host interactions (see“Host–Pathogen Interaction
and the Evolutionary Self”), the ubiquity of damage-associated
molecular patterns (DAMPs) (see “DAMPs: When The Self Shifts
Toward Non-Self”), the continuous antigenic assimilation in oral
tolerance (see “Gut Microbiota–Host Interactions and Oral Toler-
ance: When the Non-Self Becomes Self”), the overlapping between
pathogenic bacterial peptides and human peptides (molecular
mimicry) (see “Molecular Mimicry and Proteasome-Catalyzed
Peptide Splicing: When Self and Non-Self Coincide”) and the
epigenetic modifications and mechanism of glycosylation in creat-
ing antigens signals (see“Age-Associated N -Glycans Modifications
and Inflammation: When the Aged Self Becomes Non-Self”).
Finally, we will argue that the immunological self is at the
intersection of long-term, distant, evolutionary selective force
operating at the level of population and proximate immuno-
logical experiences at the level of individual’s lifetime. Genetic
and immunological evidences indicate that the IS is molded and
shaped by evolutionary forces where microbial infections played a
major selective pressure, and whose final consequences are evident
at the population level. On this evolutionary background – that
can differ from population to population on the planet according
to different environmental and epidemiological agents (46) – a
successive remodeling of the IS occurs progressively with age,
mainly driven by the individual-specific immunological biography
(i.e., the sigma of the immune stimuli that a single individual has
received lifelong) from utero to the last decades of life, in different
environments, and related to quality and quantity of pathogens
an individual has been exposed to. In conclusion, we will high-
light how the concept of liquid self is well in accordance with
recently proposed continuity/discontinuity hypothesis (47, 48),
which recovers the idea that abrupt changes in the amount of
antigen over time are critical in triggering immunity, a concept
originally proposed by Grossman and Paul (49) and now recently
expanded (50).
HOST–PATHOGEN INTERACTION AND THE EVOLUTIONARY
SELF
The host–pathogen interaction phenomena have profoundly
shaped the genetic evolution of our species. One of the most
paradigmatic examples is represented by the prevalence of tha-
lassemia in Mediterranean regions, as a result of the selective
pressure of malaria infection (51), the latter a disease that in
this case plays a defensive role by contrasting through a natural
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Box 2 What is self?
What really is the immunological self? According to Burnet, who introduced the term in 1949, the immunological self coincided with all the
cell surface pattern recognitions that are ignored by the normal immune defensive action, namely the biological constituents peculiar to each
individual. Since Burnet, there have been roughly a dozen different attempts to find an answer, but none has found a general acceptance.
They can be grouped in six major answers as follows.
The self is:
(1) everything encoded by the genome (26, 27);
(2) any tissue under the skin accessible to lymphocytes, including structures encoded by commensal genomes or excluding immune
“privileged” sites such as brain, cornea, and testes (5);
(3) the set of peptides complexed with the MHC (28);
(4) specifics like APCs and thymic epithelium (29) or soluble molecules of B lymphocytes (20);
(5) a set of bodily proteins that exist above a certain concentration (30);
(6) the immune network itself, variously conceived (31, 32).
While these versions may be situated along a continuum between a severe genetic reductionism and complex organismal constructions
(33), each shares an unsettled relationship to Burnet’s original dichotomous model of self and other (34).
Today, no longer is the identity of the host organism given or assumed, and, indeed, the definition of immune selfhood (35) embraces
at least three diverse definitions:
(1) the “organismal self” – i.e., the epistemological functional category immunologists typically employ;
(2) the “immunological self” – an ontological construction that draws from molecular definitions and builds upon Burnet’s theory of tolerance;
(3) the “immune self” – a metaphysical formulation of the system-as-a-whole.
Reformulated after Ref. (5, 7, 35).
selection mechanism, the more severe hemoglobin disorder (51,
52). While the malaria-inducing plasmodium has produced a clear
mark of its presence, other pathogens may have left signatures that
are more difficult to highlight, and probably many other alleles
are present in the population’s gene pools as a result of adaptation
to specific chronic inflammatory pressure (53). Genes involved
in immunological processes are more exposed to the selective
pressure exerted by pathogens. Indeed, comparative genomic stud-
ies have clearly shown that such genes are less conserved and
frequently targeted by positive selection than genes involved in
other pathways (54, 55). The evolutionary dynamic nature of
the IS is also described by population genetics observations. The
Wellcome Trust Case Control Consortium studies, where several
thousands of individuals were genotyped by genome-wide associ-
ation studies, reported that the genomic regions showing highest
levels of population sub-structure (i.e., that are more differenti-
ated between populations, as a result of a higher evolutionary rate)
are the major histocompatibility complex (MHC) and the genes
coding for toll-like receptor 1 (TLR1) (56). The MHC is one of the
best-known examples of balancing selection in humans, and its
extremely high level of heterozygosity is maintained by pathogen-
driven selective pressure (57). The TLR1/TLR6/TLR10 region on
chromosome 4p14 is characterized by high levels of heterozygos-
ity and high levels of non-synonymous mutations (i.e., altering
the amino acid sequence of a protein) with minimum allele fre-
quency (i.e., >0.10 in Caucasian populations), with clear marks
of positive/balancing selection. The explanation of such selective
pressure is that TLR1 receptor, in a heterodimeric combination
with TLR2, recognizes lipopeptides from Mycobacteria, the causes
of leprosy and tuberculosis (58). These observations indicate that
genetic diversity allows for increased flexibility in the immune
response that is always struggling to reach an effective equilib-
rium between fighting invaders and the tolerance of self and of
innocuous antigens (59).
In addition, some structural proteins (antigens) expressed by
pathogens such as mycobacteria have a high homology with mam-
malian proteins, good examples of these are heat shock proteins
(HSPs). HSPs are highly conserved proteins during evolution.
Besides being upregulated in stress conditions, they are con-
stitutively and abundantly present in all living beings and are
profoundly involved in various intracellular and systemic home-
ostatic functions in different species (60, 61). These proteins
have been considered by Irun Cohen (62) as immunodominant
antigens for self immune responses and as key players in physi-
ological autoimmunity, likely to be involved in homeostasis (63).
In line with this idea, self-HSP-reactive T and B cell clones can
be seen as an important part of a network of regulatory cells
and molecules in the IS engaged in homeostatic activities (64).
These activities would include tissue maintenance and repair,
but also limiting clonal expansion and controlling inflammation.
Interestingly, anti-HSP antibodies and HSP60-reactive T cells are
part of immune responses in several infectious diseases (65).
Approximately 10–20% of the specific T cells in mice immu-
nized with Mycobacterium tuberculosis are against the bacterial
HSP65 (66). Antibodies to HSP60 of Chlamydia trachomatis have
been detected at high levels in the sera of infected patients (67),
and immunodominant responses to HSP60 are present in other
fungal infections (68). This strong immune response directed to
HSP60 during infection can be explained by its critical role in
cellular homeostasis and by its upregulation in host tissues as a
result of stress during infection. According to Cohen, response to
such homologous antigens would have a key role in connecting
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the immune response to pathogens to an internal web of reg-
ulatory circuits [mostly of regulatory T cells (Treg)] that could
regulate specific immunity as well. These regulatory cells would
control inflammatory responses to pathogens keeping them from
damaging body tissues (62). Indeed, most of the pathological
aspects associated with chronic infections are associated with
the inflammatory responses that the infectious agents trigger in
the host.
Taken together, all these clues strongly support the hypothesis
that the host–pathogen interaction is the most crucial challenge
Homo sapiens has faced during evolution. This interaction has led
to the development of a vast arsenal of sophisticated weapons to
fight a vast repertoire of pathogens, and vice versa to a variety
of strategies that pathogens have evolved to evade the immune
response. The drastic reduction of potential pathogens repertoire
that we were usually exposed to in the (recent) past, particularly
in the last century in western countries, has created a mismatch
between these new environments and the one toward which the
IS was adapted along the course of its evolution. While in the
developing countries infectious diseases account for about 48%
of deaths among people with 45 years or less of age (69), in the
industrialized world the radical changes of the human environ-
ment and the development of efficient healthcare systems have
resulted in a drastic reduction in the diversity/quantity of micro-
bial species we usually deal with (70). Paradoxically, despite being
a major and well recognized contributor to the recent increase
of the lifespan in western countries, this consistent reduction
of IS stimuli/antigens has in turn favored the development of
chronic inflammatory conditions and autoimmune diseases (71),
according to the so-called hygiene hypothesis (72). Specifically,
quantitative and qualitative alterations of T regulatory (Treg)
lymphocytes, key players in modulating immune reactivity and
inflammation, imply an alteration of the inflammation home-
ostasis, leading toward autoimmune reactions (73). The human IS
has co-evolved with many pathogens, including intestinal sapro-
phytes and some helminths, against which the immune response
is switched off (74). Many receptors, including TLRs, expressed
on immature dendritic cells, are stimulated by antigens shown
by the tolerated saprophytes and helminths, and this interaction
stimulates the maturation of dendritic cells that in turn promote
the Treg cells-mediated responses to these organisms. This mech-
anism is a key regulator of the basal inflammatory tone and of
the homeostasis of the immune response. By having reduced the
number of these antigenic interactions, the new hygienic condition
in industrialized countries has consequently reduced the stimula-
tion of Treg cells: a process that may lead to a disruption of the
homeostasis and to the alterations of the basal inflammatory tone,
thereby opening the door to an increasing incidence of autoim-
mune pathologies (59). In this complex stage, and on a wider
scale, the human geographical dimension seems to play a consis-
tent role. It has been observed that tropical Africans are specialized
at fighting parasites with low virulence and extended life spans,
while Europeans and perhaps Asians are better adapted to high
virulence pathogens (75), suggesting that evolved responses to
diverse pathogen loads among geographic groups may contribute
to higher frequencies of inflammatory diseases in contemporary
communities.
As pointed out by Ward and Rosenthal, TLR diversity is wider
in echinoderms but smaller in mammals (76). Such TLR diversity
goes in parallel with a multiplication of cytokine receptors and of
the STAT adaptor proteins. This framework suggests that with the
initiation of adaptive immunity, the abundance of innate immune
receptors was selectively reduced, and the role of PRRs shifted to
initiators of downstream signaling for the adaptive immunity (76).
Organisms that developed a costly, complex, and specific system
for fighting infection maintained the core of innate IS with the
ability to activate it in an effective way.
Therefore, it is possible to speculate that the large number of sea
urchins’ TLRs and the less TLRs in mammalian species are them-
selves a documentation of fluidity in the innate and adaptive world
that represents our convoluted and highly evolved “self,” and that
hard-wired recognition of “non-self”was too“dangerous” for con-
tinuity with an adaptive immune response in hand. An excessive
number of “rough”recognizing events would have likely been dan-
gerous and costly in this new “adaptive” situation. Indeed, there
are additional evidences that evolutionary history of European
populations has identified several immune pathways, and in par-
ticular TLR1/TLR6/TLR10-related pathways, as being shaped by
convergent evolutionary pressure in two human populations with
different origins under the same infectious environment, taking
into account both their geographical and immuno-biographical
characteristics (77).
Moreover, other types of immunologically important proteins,
such as the five cytosolic toll/IL-1 receptor (TIR) adaptor proteins,
now increasingly recognized to play a crucial role in the speci-
ficity of the response, evolved in humans by a swinging game
between constraint pressure and adaptation (78), i.e., what, at
the population level, we can consider equivalent to a “dirty” or
a “clean” environment. Indeed, studies on human populations of
host defense genes (with parallel roles in model organisms) have
shown divergent evolutionary paths among the distinct receptor
and adaptor proteins of the innate IS. These data are compatible
with the hypothesis that natural selection exerts a strong effect on
IS genes as a consequence of host adaptation to novel, diverse, and
coevolving pathogens. In particular, the data suggest that the con-
temporary diversity of the five TIR adaptors arises from multiple
events related to the pressure of specific constraints plus adaptive
evolution, resulting in a dynamic divergence in time and space,
even stronger than that observed on TLRs (78).
As an immuno-biographical example, we reported that in
human subjects with very long and diverse immunological expe-
rience (nonagenarians and centenarians) the “immunological
space” is filled with expanded clones of T cells specific for few epi-
topes of common and persistent viruses such as cytomegalovirus
(CMV) and Epstein–Barr virus (EBV) (79,80), concomitantly with
a remarkable shrinkage of CD4+ and CD8+ T cell repertoire
(81). Such adaptive outcomes can be considered a good exam-
ple of how large the changes occurring in the adaptive IS with
time/age/immunological experience can be. In a previous the-
oretical contribution (82), we argued that a significant amount
of “degeneracy,” defined as the ability of structurally different
elements to perform the same function (83), is required by the
inherent complexity of IS in order to operate effectively, and that
such degeneracy of T cells, as well as of other IS sensors (84, 85),
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likely represents a most important structural basis of the liquidity
of the immune self. Most importantly, degeneracy is a prominent
property of evolution itself and it has been primarily proposed as
a evolutionary strategy: degenerate structures, indeed, are func-
tionally overlapping and rearrange their configuration to meet
internal or external (environmental) changes thanks to their inter-
changeable task capabilities, something that makes them capable
of yielding unforeseen functionalities, and may thus show evo-
lutionary advantage (83). Along these lines, we see the recent
degenerate mechanism of the liquidity of self as a proximate cause
of a long running evolutionary strategy of adaptation.
Finally, we surmise that the liquidity of self, possibly present at
low level even in invertebrates, likely “exploded” with the appear-
ance of adaptive immunity and its unprecedented capability to
generate large T and B repertoires. A more adaptable and flex-
ible immunity was carrying in itself the hallmarks of a mod-
ular detection of SNS, able to transform upon space and time
changes. In the new evolved self also innate immunity plays a
role in keeping self liquid (TLR1/6/10 genetic evolution in human
population) but our theory of liquid self describes the IS and
SNS detection of an organism, which has a predominant highly
differentiated and modular adaptive immunity. Adaptive immu-
nity and liquid self walked through the gate of evolution side
by side.
DAMPs: WHEN THE SELF SHIFTS TOWARD NON-SELF
Damage-associated molecular patterns (also known as alarmins)
are molecules released by injured cells undergoing necrosis and
apoptosis (86) that act as endogenous danger signals able to pro-
mote inflammatory responses. Increased serum levels of DAMPs
have been associated with several inflammatory diseases, includ-
ing arthritis, atherosclerosis, lupus, Crohn’s disease, and cancer.
DAMPs are perceived by the innate IS by PRRs that are also able
to sense PAMPs. Recently, evidences of DAMPs resulting from
nucleus, endoplasmic reticulum (ER), cytosol, and plasma mem-
brane, as well as mitochondria-derived DAMPs (mito-DAMPs)
have been reported. In particular, mito-DAMPs seem to occupy
a central position as modulators of inflammation during dif-
ferent pathologies that are accompanied by massive cell death
and/or tissue damage (87, 88) (e.g., 95% of patients with primary
biliary cirrhosis have high titers of anti-mitochondrial antibod-
ies (89), confirming that the dominant auto-reactive response is
mounted against the 70 kDa mitochondrial antigen). It has been
also observed that circulating mtDNA increases with age, and
can significantly contribute to the maintenance of the low-grade,
chronic inflammation (inflammaging) observed in elderly people
(90). Such considerations suggest that mito-DAMPs, and related
immune pathways, may be among the causes, hence possible tar-
gets, for the treatment of autoimmune and autoinflammatory
diseases.
Metabolites such as nucleotides (ATP) or nucleosides
(adenosines) once gained the extracellular milieu after cellular
disruption act as danger signal and alert immune responses (91),
although danger signaling is not only due to misplacement of
such metabolites but also to their quantity. Indeed, the role of
ATP could shift from up regulation of costimulatory molecules
turning on inflammation at low concentration, to the blockade
of the synthesis of the pro-inflammatory cytokines at higher
concentration (92–94).
In conclusion, being endogenous and ubiquitous, mito-DAMPs
would be unaccountable according to a substantially static SNS
(ontogenetic) dichotomy. Taking into account that mtDNA has
an ancestral bacterial origin, its capability to become a strong
inflammatory stimulus when released outside the cell can be taken
as a paradigmatic example that self DAMPs can trigger innate
immunity receptors shifting toward non-self. HSPs, HMGB1, and
fibrinogen can be taken as further examples of self molecules
showing such “borderline” capability of activating TLRs (95, 96).
The steady increase with age of circulating mtDNA reported in
Ref. (90) also suggests that there is a continuum from young
age to nonagenarians and centenarians regarding the possible
role of mito-DAMPs to became detrimental and contribute to
inflammaging, assumed as the background of major age-related
diseases. When such age-related inflammation starts becoming
detrimental, the entire scenario of DAMPs as self or non-self
also starts to become quite blurred. In this framework, it is dif-
ficult or even impossible to trace the initial/original cause of
the entire, dynamic inflammaging process, which is dominated
by a series of vicious circles implementing and amplifying each
other.
GUT MICROBIOTA–HOST INTERACTIONS AND ORAL
TOLERANCE: WHEN THE NON-SELF BECOMES SELF
The intestinal mucosa lodges the largest lymphoid tissue. The gut-
associated lymphoid tissue (GALT) contains a number of plasma
cells and lymphocytes exceeding the number found in the other
lymphoid organs altogether (97). This large lymphocyte-rich sur-
face contacts daily an equally large collection of natural antigens
coming from two sources: gut microbiota and diet. It is estimated
that we eat 190 g of protein antigens daily and that the number
of bacteria colonizing the human intestine is around 1012 bacte-
ria/g of stool (98). Thus, the gut microbiota provides a variety of
antigenic components continuously, and a significant part of the
dietary proteins reaches the circulation in its intact immunogenic
form (99) (Box 3).
There are two major consequences that follow the contact
between these antigens and the gut lymphoid tissue: the produc-
tion of secretory immunoglobulin (Ig) A and the induction of oral
tolerance. The secretory IgA (SIgA) is a non-inflammatory sub-
class of immunoglobulin that is present in all mucosal secretions
and can remove pathogenic microorganisms without inflamma-
tory responses (107). Oral tolerance is a phenomenon known in
medical literature since 1909 when Besredka showed that guinea
pigs fed with milk-containing chow could not be immunized
against milk proteins (108). In this scenario, tolerance means the
suppression of inflammatory immune responses to the fed antigen
and it has a close resemblance to the tolerance toward self compo-
nents. Since this first description until very recently, oral tolerance
has been only marginally quoted, probably due to the fact that
a tolerance acquired to non-self food antigens represent a hard
challenge to the SNS paradigm. In the 1970s oral tolerance was the
topic of some systematic and important studies since suppressor
T cells were proposed to explain the inhibitory effect generated by
feeding antigens (108, 109). With the recent revival of Treg cells
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Box 3 Nutrition and meta-organismal symbiosis.
The commensality of a superorganism: Human native microbial population is constituted by 10–100 trillion bacteria that reside in the gastroin-
testinal tract (100).Their joint genome, defined as microbiome, has been estimated to include ≥100 times as many genes as the 2.85 billion
base pair human genome (100), and it is able to perform tasks that humans have not evolved on their own (101). In this perspective, human
beings should be reconsidered as “superorganisms” in co-evolution with their own microbiota, thereby possessing a “metagenome” (102).
The gut microbiota is composed by different bacterial strains and species with considerable interpersonal variation, which evolved to exert
a strong influence on the human metabolic phenotype.
Accordingly, the gastrointestinal IS evolved the capability to distinguish between harmful pathogens and harmless symbiotic (commen-
sal) microorganisms, generating a strong effector response toward the former and remaining unresponsive to the latter. The gut bacteria
can be roughly divided into three classes on the basis of the intensity of the host response in intestinal epithelial cells (IECs) and dendritic
cells (DCs): (i) pathogenic microorganisms, which are virulent and induce a strong host response; (ii) probiotics, which modulate certain
IEC and DC functions and induce an intermediate response; (iii) and commensal bacteria, which exhibit homeostatic control of the immune
response (103).The reaction of gastrointestinal IS toward gut microbiota is in part triggered by signaling interactions of the surface molecules
of probiotic bacteria (such as long surface appendages, polysaccharides, and lipoteichoic acids) with host PRRs and by bacterial cell surface
macromolecules, which are key factors in this beneficial microorganism–host crosstalk (103).
Immune system and microbiota: crosstalk, modulation, and cohabitation: The modes of action by which probiotics are thought to
contribute to human health fall into three main categories. First, certain probiotics can exclude or inhibit pathogens (through competi-
tion/cooperation for nutrients, antimicrobial production, competitive exclusion, cell–cell communication processes explicated by means of
adhesions, lactic acid, bacteriocins quorum-sensing signals, etc.). A second mechanism enhances the function of the intestinal epithelial
barrier by modulating the various signaling pathways that lead, for example, to the induction of mucus and defensin production, the enhance-
ment of cell tight junction functioning, and the prevention of apoptosis. The third mechanism modulates the host immune responses, by
regulating the cytokine expression, with local and systemic effects on phagocytosis, modulation/induction of DCs and different pro- and
anti-inflammatory T cell subsets (Th1, Th17, and Treg lymphocytes).
Intriguingly, gut microbiota showed to modulate the IS not only in the gastrointestinal tract but also in other human compartments like
the central nervous system with potential implication in autoimmune diseases such as multiple sclerosis (104). Tolerance and cohabitation
between microbiota and IS are owed to an incredibly complex, balanced network of interaction and cross-influences among elements of
the two systems, and to a highly dynamic maintenance of very special environment and interface.
Indeed, mucosal surfaces are the largest contact area of the body with its environment. The human intestinal mucosa alone is 100-fold
larger than the skin (105). Moreover, this specialized surface is covered by a single layer of epithelial cells with absorptive properties. In this
perspective, the gut mucosa can be viewed as an interface rather than a barrier between the “inside” and “outside.” Environment-derived
materials find in the enterocytes and the specialized epithelial cell called M cells of the gut act as a selective but permeable gate of entrance
into the body.
Lymphocytes that compose the gut-associated lymphoid tissue (GALT) are either part of lympho-node-like structures such as Peyer’s
patches or scattered throughout the lamina propria and intraepithelial spaces of the intestine in such a way that it is impossible to distinguish
functionally epithelia and lymphoid components. B-cell-deficient mice, for instance, have a defect in the formation of M cell (106), thereby
suggesting that B lymphocytes are not only lodged there but also provide signaling molecules for the differentiation of the gut epithelia.
and their important role in maintaining central as well as periph-
eral tolerance, the suppression induced by oral administration of
antigens came back into the scene, being the oral route a very effi-
cient way to induce peripheral tolerance both in animal models
(110) and in humans (111). Oral tolerance probably accounts for
the robust balance that keeps the homeostasis of intestinal mucosa
with its highly activated lymphoid tissue (108). We are all tolerant
to the food proteins that we ingest and also to our microbiota, as
documented in mice and humans (111–113).
This hyporresponsiveness achieved by feeding, however, does
not imply antigenic ignorance; it rather depends on active immune
recognition and non-inflammatory responses. In fact, the mecha-
nisms involved in oral tolerance seem to be similar to the ones
triggered during central tolerance in the thymus, by inducing
anergy/deletion of specific T cells and of Treg cells (108). Indeed,
CD4+T cells can be converted into CD25+ activated forkhead box
P3 (FoxP3+) regulatory cells in the intestinal mucosa by the action
of CD103+ specialized dendritic cells (DCs) that secrete retinoic
acid (114, 115). Other regulatory cells able to secrete transform-
ing growth factor-β (TGF-β) are also generated in the intestine
and these cells are involved in the gut homeostasis and in the
induction of tolerance to antigens that reach the body through
the gut (114). Therefore, the GALT has thymus-like mechanisms
that are able to treat the antigens coming from the diet and from
the autochthonous microbiota as if they were self antigens. The
similarities between oral tolerance and natural tolerance was the
inspiration for a large number of successful studies showing that
autoimmune disease models can be either prevented or treated by
oral administration of self components (110).
It has been already shown that the state of tolerance to self as
well as oral tolerance to fed antigens is concomitant to a highly
immune activated state (116, 117). Indeed auto-reactive antibod-
ies as well as auto-reactive T lymphocytes can be found in healthy
individuals. Autoantibodies of the IgM, IgG, and IgA classes,
reactive to a variety of self components such as serum proteins,
cell surface structures, and intracellular structures are “naturally”
found in all normal individuals (118). These natural antibodies are
produced mainly by B1 cells and were shown to be polyreactive
(119, 120). SIgA is also known to be produced by B1 as well B2 cells
in the gut lamina própria. Gut B1 cells secrete IgA in a T-cell inde-
pendent fashion and these antibodies are highly polyreactive (121,
122). Interestingly, Quan and coworkers (123) have also shown
that SIgA found in the intestinal lumen could be the secretory
counterpart of the natural antibodies in serum. Significant levels
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of SIgA antibodies to human actin, myosin, tubulin, and spectrin
have been detected in saliva and colostrum samples from nor-
mal subjects. In addition, a recent study shows strikingly that
antibiotic-induced changes in gut microbiota have strong influ-
ence on the TCR repertoire of host Treg cells selected in the thymus,
and not on induced Treg cells (124).
Another interesting aspect of the immune reactivity initiated
at the mucosal sites is that these natural antigens have a critical
role in the development of the IS itself. Since weaning up to adult-
hood, mice that are fed with a diet where antigenic-intact proteins
are replaced by amino acids bear an immature IS and a poorly
developed GALT. They showed decreased levels of SIgA and, more
remarkably, they had lower levels of serum IgG and IgA, and a
profile of cytokine production biased toward T helper 2 (Th2)
resembling neonates (98). Similar alterations were described in
adult germ-free mice (125), indicating that the removal of anti-
gens from diet or microbiota hampers the regular development of
the IS.
Therefore, if we think about nutrition as a process implying
a continuous construction and shaping of the immune self, then
dietary antigens and autochthones microbiota, actively participat-
ing in food digestion, represent exactly a blurry, liquid zone where
foreign materials become autocomponents and are treated as such
by the IS.
The human gut-associated lymphoid tissue keeps the intestinal
microbiota under control by a “constitutive low-grade physio-
logical inflammation,” which is grounded on a net of positive
and negative feedback processes. The particular biological archi-
tecture of the gastrointestinal mucosal IS allows the distinction
between harming pathogens and symbiotic microorganisms, caus-
ing a robust effector reaction toward the former and remaining
tolerant to the latter. However, non-infectious human diseases
characterized by an abnormal intestinal inflammation, such as
inflammatory bowel diseases, metabolic syndrome, allergies, as
well as genetic defects in enterocytes PRRs system, can trig-
ger a failure of the homeostatic equilibrium at the interface
between the intestinal microbiota and the host. In this perspec-
tive, it has been suggested that the inflammatory process could
be triggered and fostered by an aberrantly activated immune
response to the constituents of the gut microbiota, which may
be due either to a reduced mucosal tolerance, or to the age-
related alterations in the gut microbiota composition, or to both
(126). Nutritional deficit and age-associated tissue fault and
injuries may also contribute to trigger a pathogenic inflamma-
tory response in the presence of normally harmless symbiotic
bacteria (127).
Studies (128) provided a deeper outlook of the associa-
tion between the gut microbiota composition and the levels of
numerous serum inflammatory markers. A reorganization in the
population of butyrate producers and other bacteria with anti-
inflammatory properties was observed in a model of an extremely
aged and consequently compromised microbiota. The subsequent
dysbiosis may be among the origins – or the consequences – of
the increased proliferation of opportunistic enterobacteria, which
appeared to be positively correlated to an increase in certain pro-
inflammatory signals (IL-6 and IL-8). The authors conjectured
that the age-related increase of pathobionts can either contribute
to inflammaging, or be fostered by the systemic inflammatory
status.
Finally, human beings have been recently considered as
“metaorganisms” as a result of an intimate symbiotic liaison with
the intestinal microbiota (100, 129). This postulation forces a more
holistic vision of the aging process, where dynamics of the interac-
tion among environment, intestinal microbiota, and host must be
taken into consideration. Starting from birth, a dynamic microbial
ecosystem develops from a sterile environment and colonizes the
gut ecosystem (130). Later on, the developmental modifications in
the gut mucosa and in the intestinal IS, and the introduction of a
solid diet drive the shift to a resilient adult-like profile of the human
gut microbiota, characterized by a significant microbial biodiver-
sity. The aging of the gut microbiota begins after a subject-specific
“threshold age,” which depends on individual features such as diet,
environment, country, and eventually, frailty. In any case, alter-
ations of nutrition regimen, lifestyle, and the immunosenescence
of the intestinal IS dramatically impact the microbial ecology of
the human GI tract, and conversely, the manipulation of the gut
microbiota may result in modification of the functionality of an
aged IS (131).
MOLECULAR MIMICRY AND PROTEASOME-CATALYZED
PEPTIDE SPLICING: WHEN SELF AND NON-SELF COINCIDE
Molecular mimicry phenomena are suggested to be among
the causes of pathogenic autoimmunity. Molecular mimicry is
supported by the homology of human-derived sequences and
pathogen proteome, as well as by the phenomenon of T cell
receptor (TCR) degeneracy (85), whereby epitopes with differ-
ent sequence are recognized by the same TCR (132). It is known
that the TCR is able to operate at the level of the single recep-
tor (affinity of the TCR-ligand bond) as well as at the emerging
level that derives from integration of multiple signals by the col-
lective of interacting cells (concentration of TCR ligands and
related number of bound TCRs) (82, 133). This condition deter-
mines a continuum of inputs to the TCR (“TCR signalosome”)
determining the various cell functional outcomes (133), which
is difficult to relate to a rigid concept of ligand structure and
of self.
So far, TCR degeneracy seems to play a stronger role for
MHC class II-restricted than I-restricted epitopes, and therefore it
appears to be more relevant for the activity of CD4+ T cells (134)
as demonstrated in some autoimmune diseases such as multiple
sclerosis (135).
Viruses, bacteria, and human proteome share a limited num-
ber of 9-mer peptide sequences. Such a number is higher between
bacteria and human proteome than between virus and human
proteome, although the degree of overlap between bacterial and
human proteomes does not correlate with bacterial pathogenicity
(136, 137). Such observation is relevant because the epitopes that
are bound to MHC class I molecules and presented to CD8+ T
cells are generally 9-mers. These epitopes are usually generated by
proteasomes, which by their selective cleavage preferences, deter-
mine which epitope sequence will represent human or pathogen
antigens on the surface of APCs. The proteasome is the cen-
tral catalytic unit of the ubiquitin proteasome system, which is
responsible of the non-lysosomial degradation of the 80–90% of
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proteome (138). A small part of the produced peptides is trans-
ported to the ER, bound by MHC class I molecules and presented
at the cell surface to CD8+ T lymphocytes for the immune recog-
nition. This antigen presentation pathway is usually restricted to
the proteasome-dependent processing of self- and viral-proteins
because of the cellular compartmentalization of the antigens. Pro-
teasomes take also part to the presentation of bacterial antigens as
well as of cytoplasmic antigens loaded to the MHC class II (139,
140). Therefore, the proteasome generates the majority of pep-
tides that label self and non-self antigens for the T cell-mediated
inflammation. Antigen presentation is generally increased after
interferon-γ (IFN-γ) stimuli because it induces, amongst the
others, the synthesis of alternative proteasome catalytic subunits
and the concomitant formation of immuno-proteasomes (141).
Standard- and immuno-proteasomes differ in their preferential
cleavage of peptide sequences (Mishto et al., personal commu-
nication). However, they generate same MHC class I epitope
repertoires although in different amount (Mishto et al., personal
communication). Such quantitative differences could explain the
qualitative differences in epitope repertoires generated by the two
proteasome isoforms described in some studies (142–145).
Often, immunoproteasome has been shown to better gener-
ate MHC class I-restricted viral epitopes, whereas several self
epitopes (including tumor epitopes) have been described to be
better generated by standard proteasome (146–148). Such appar-
ent dichotomy between viral and human proteome epitopes is
not due to discrimination at proteolytic level between self and
non-self by proteasome isoforms. On the contrary, it caused by
the fact that the identification of MHC class I-restricted epitopes
often depends on the ex vivo isolation from the peripheral blood
of CD8+ T cells. These cells escaped the negative selection in
the thymus, because they did not efficiently recognize self MHC
class I-restricted epitopes presented by thymic APCs. The latter
cells express mainly immunoproteasome. Consequently, in the
thymus the presentation by APCs of those epitopes that are bet-
ter produced by immunoproteasome leads to a depletion of the
reactive thymocytes. On the contrary, the thymocytes that react
against epitopes better generated by standard proteasome could
maturate, migrate outside the thymus, and become potentially
auto-reactive and anti-tumoral cytotoxic T lymphocytes (CTLs).
In summary, although standard proteasome do not generally bet-
ter produce self epitopes, the absence of this proteasome isoform
in the thymus could permit the survival of CD8+ T cells that
recognize self epitopes, including tumor-associated epitopes that
are better generated by standard proteasomes. Because viral epi-
topes are not presented in the thymus, such a discrimination
toward CD8+ T cells specific for epitope preferentially generated
by immunoproteasome does not occur (149).
The different expression of proteasome isoforms in thymus
(mainly thymus- and immuno-proteasomes), in dendritic cells
(immunoproteasome), and in parenchyma cells (mainly standard
proteasome) (150) influences, from another angle, the definition
of SNS. Indeed, the same human proteome-derived antigen is rep-
resented by quantitative different repertoire of epitopes exposed
onto the MHC class I molecules according to the proteasome
isoforms present in the cells that is exposing the epitopes. There-
fore, a variation of the proteasome population as occurs upon
inflammation or chronic pathologies may lead to the recognition
of human antigen as non-self (151). One more time, it is important
to bear in mind that such alteration of the MHC class I-restricted
epitope repertoire upon alteration of the proteasome population
are only quantitative.
Among the tumor-associated MHC class I-restricted epitopes,
it is worthy to mention also epitopes produced by proteasome-
catalyzed peptide splicing (PCPS). Indeed, proteasomes produce
peptides during the degradation of proteins by a simple hydrolysis
or by PCPS. PCPS is a cut and paste reaction, which can occur
also by binding two peptides derived from distinct polypeptides
(trans PCPS) (152, 153). PCPS has been demonstrated in vivo only
for four MHC class I-restricted epitopes (152, 154–157) although
a sizeable number of proteasome-generated splicing peptides has
been identified by digesting in vitro different polypeptides (153,
158). Intriguingly, the proteasome-generated splicing peptides are
more prone than normal cleavage products to be potential MHC
class I-restricted epitopes because of structural characteristics of
PCPS catalytic sites (158).
These recent inputs could impact on the definition of SNS from
at least two different points of view. First, PCPS increases the pos-
sible number of epitopes generated from human or pathogen pro-
teomes (159) thereby increasing the chances of molecular mimicry.
Second, PCPS might be theoretically generated by the ligation of
peptides derived from two distinct proteins (trans PCPS) (152,153,
158). In case both human and viral proteins had been processed by
trans PCPS, we might observe the formation of chimeric epitopes,
half human half virus. In our opinion the likelihood that such
chimera epitopes are produced in normal conditions is extremely
low. However, during an acute viral infection, where infected cells
are forced to synthesize viral protein in high amount, the chances
of a PCPS event between human and viral peptides might signifi-
cantly increase becoming something more than a purely academic
speculation.
AGE-ASSOCIATED N -GLYCANS MODIFICATIONS AND
INFLAMMATION: WHEN THE AGED SELF BECOMES
NON-SELF
Glycosylation is a form of co-translational and post-translational
modification that attaches glycans to proteins, lipids, or other
organic molecules, affecting protein folding and stability as well
as influencing their biological activity. Glycosylation patterns reli-
ably reflect cellular phenotypic state and appearance of altered
carbohydrate structures may constitute a pivotal phenotypic alter-
ation that alarms the IS to danger and initiate a reaction. Recently,
a model has been proposed that considers the cellular glycosyla-
tion status as a critical indicator of cellular health status, and that is
being interpreted by the IS via the carbohydrate receptors involved
in the regulation of effector cells (160). A tight linkage was identi-
fied between the concentration of N -glycans depleted of galactose
residues and the aging process, progeroid syndrome, and a variety
of autoimmune and inflammatory diseases (160). The agalacto-
sylated structures are prevalently found linked to the asparagine
residue 297 of IgG (IgG-G0), the main serum immunoglobulin.
Indeed, the percentage of IgG-G0 tend to increase with age having
the lowest concentration at the age of 25 years (161–163). Recently,
studies performed with high-throughput technologies confirmed
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the association of agalactosylated structures with chronological age
and reported for the first time that the age dependent hypogalac-
tosylation is not restricted to the IgG fraction of serum antibody,
but is common with the other serum glycoproteins. A study on
healthy centenarians in comparison with people aged 60–90 years
reported that in the above-90 years cohort, the increase of the
concentration of agalactosylated structures and the concomitant
decrease of digalactosylated structures (the so-called Gly co-age
test) characterize also the extreme elderly (164, 165).
The IgG-G0 serum concentration is not only a putative marker
of chronological age, but also of biological age. Indeed, a study
based on the Leiden longevity study, a longevity model based on
nonagenarian sibling pairs, offspring and their partners as con-
trol, revealed that the IgG-G0 concentration was lower in the
offspring cohort than in the partners’ ones, indicating that the
offspring cohort seem “less aged” that the age matched controls
(166). Moreover, a clear link between the increase of IgG-G0 and
altered inflammatory pathways was identified and several mech-
anisms of pro-inflammatory action were described. The IgG-G0
possesses a five-fold complement activation activity than other
IgG. This enhanced activity is due to the high affinity that IgG-
G0 has with mannose-binding lectin that activates complement
through the lectin pathway (167, 168). Moreover, IgG-G0 inter-
acts with lectin receptors, such as the mannose-binding recep-
tor and DC-SIGN, of macrophages and dendritic cells (DCs),
thereby increasing the lectin uptake sustaining the inflammatory
process (169, 170).
Taken together these observations strongly suggest a link
between the IgG-G0 imbalance and inflammation. In this per-
spective, the simple IgG-G0 accumulation observed in age is a
transformation of physiological pattern into a pathological one
(altered carbohydrate structures), or in other words of self to
non-self that triggers inflammatory responses (171).
In a recent study about the role of epigenetics in human
aging and longevity, one of us observed an age-related drop in
global DNA methylation and a delay of this process in cen-
tenarians’ offspring (172). Remarkably, literature data suggest
a relationship between the drop of DNA methylation detected
during aging and the occurrence of age-associated diseases (173–
176). Genome-wide methylation analyses evidenced DNA methy-
lation profiles specific for aging and longevity, showing genes
involved in nucleotide biosynthesis, metabolism, and control of
signal transmission are differently methylated in centenarians’
offspring (vs non-centenarians’ offspring) hypothesizing a role
for these genes in human longevity. Such results suggested that
a better preservation of DNA methylation status, a slower cell
growing/metabolism, and a better control in signal transmission
through epigenetic mechanisms may be involved in the process
of human longevity. In particular, the identification of a relevant
number of age-related hypomethylated loci significantly enriched
of genes associated with inflammatory response suggests a role
of epigenetics in the modulation of inflammatory processes in
aging (172).
TESTABLE PREDICTIONS AND FALSIFIABILITY
To validate our hypothesis, we need to demonstrate that the vari-
ous parameters of immunological biography (procedural, timing,
space, geography, etc.) alter the self during lifetime. To conceive
a test, we hypothetically need genetically identical organisms that
the more they age in different conditions (reared separately), the
more differently they will react to the same antigenic stimulus.
About the contribution of environmental factors in shaping the
immune self, monozygotic (MZ) twins seem to us the best model.
Far more complex is to figure out the type of the immune stimu-
lus and its quantitation. Thus, we have focused our attention on
a series of well-established experiments in MZ twins as possible
model to test the liquid self hypothesis.
- Studies in twin vaccinology demonstrate that genetics con-
trols the early phase of the vaccine antibody response, whereas
environmental determinants predominantly influence antibody
persistence and avidity maturation (177). The role of timing and
the consequential long-term effect of a single immune insult
can be also evaluated in unrelated individuals. In 12-month
infants, for instance, avidity and isotype maturation of measles
vaccine-induced antibody are affected by age, proving insight
into ontogeny of the immune response to measles vaccine (178).
- Accumulated evidences support the notion that environmental
factors can have a long-term effect on epigenetic profiles and
influences the susceptibility to disease in MZ twins, which at
certain age shows a variable degree of discordance with respect
to different features. In relation with autoimmune diseases,
the identification of DNA methylation changes, DNA methyl-
transferases and histone modification enzymes in individuals
who develop various autoimmune diseases, are attracting the
attention of researchers in the epigenetics field (179, 180).
- In identical MZ twins that underwent kidney transplant, the
intra-uterine effects, epigenetic differences, differential antena-
tal environmental factors as well as age may cause a recipient to
develop antibodies to minor or non-HLA antigens, which may
impact graft survival (181).
- Human CMV is a common herpes virus establishing lifelong
persisting infection, which has been implicated in immunose-
nescence and mortality in the elderly. Evidences from the Leiden
longevity study and the longitudinal study of aging Danish twins
suggest that susceptibility to CMV infection, even under contin-
uous within-partnership exposure, appears to be more strongly
influenced by early-life environment than by genetic factors and
adult environment (182).
- Differences between the members of MZ twins possibly related
to environmental and “immune-biographical” differences can
also be found in other reports. For example, Tazi and coworkers
(183) showed that MZ twins infected at birth from the same
blood transfusion contaminated with HIV-1 had not only very
different clinical outcomes (twin A relatively healthy and with
slower disease progression compared to twin B) but also phy-
logenetic differences, higher growth rates and higher genetic
diversity in the HIV population.
- Variable incidence rates in invasive disease and vaccine per-
formance among different populations are also important to
support the idea that IS is molded and shaped by evolutionary
forces. As an example, the incidence of invasive Haemophilus
influenzae type b (Hib) disease among the Navajo and White
Mountain Apache children is 20 times greater than that observed
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among coeval children in the general US population, despite the
general decline of the disease after the implementation of Hib
vaccine (184). Similarly, relatively high Hib carriage rates are
observed in Alaskan natives despite high rates of vaccine cover-
age (185). Moreover, efficacy of the same Hib conjugate vaccine
is different in Finland and Alaska (186). Although such phenom-
ena may be caused by both environmental and genetic factors,
different antibody response to Hib vaccine is also present among
twins (46), revealing the link between proximate immunological
experiences at the level of individual’s lifetime with long-term,
distant, evolutionary selective force operating at the level of
population.
Given these premises, we surmise that a testable prediction
of the liquid self hypothesis should be designed as follows: two
(groups of) genetically identical inbred mice should be reared in
two different “clean” and “dirty” environments (in terms of quality
and quantity of feeding, immune insults, stress, microbial environ-
ment). The immune self of these two differently aged, reared apart
mice should after a consistent time (e.g., 2 years) be changed in
a significant way. Accordingly, they should respond in a different
way to several different immune stimuli, regarding quantity and
quality of the immune response, from low-grade stimuli to an
“immunological storm” such as a transplant. In particular, in the
case of an isograft between the two differently reared mice, the
absence of any sign of rejection would disprove the validity of the
liquid self theory. On the contrary, if the presence and the inten-
sity (quantification) of the immune response, the length of the
period before the possible rejection will be significantly different
in comparison with a transplant between two mice of the same sex,
strain, and litter but reared in the same environment and exposed
for 2 years to the same diet and so on, then this would mean that
the immunological identity varies significantly and that self is age-
and geography-dependent.
Instead of the dualistic acceptance or rejection of grafts, or com-
plete absence/presence of immune reaction to a vaccine, we can
also consider a more realistic situation where consistent variations
in immunological parameters (antibody concentration, avidity,
number of T regulatory cells, cytokine levels, among other) can
occur as a consequence of a different immunological biography.
We will consider this type of scenario in good agreement with our
liquid self theory, even if we agree that this type of evidence is
not a crucial demonstration. Indeed, immunological biography is
expected to change the self along a continuum of states, in a liquid
fashion, and does not forcedly predict a drastic overturning of the
immune self.
CONCLUSION AND PERSPECTIVE: TOWARD A NEW
CONCEPTUALIZATION OF IMMUNOLOGICAL IDENTITY
At present the danger/damage theory is the most comprehensive
theory on immunological self and represented a breakthrough in
the discipline by reorienting the response of the IS toward enti-
ties that do alert (danger) and cause a damage rather than toward
those that are foreign.
However, the danger theory and its recent refinements, being
focused on the characteristics of the molecules capable of trig-
gering an immune response, did not pay enough attention to
the responding host. Indeed, organisms capable of an immune
response belong to different populations or strains characterized
by different genetics, different immunological experience related
to lifestyle, exposure to specific pathogens, among others (75).
Within this perspective, nutrition has a particular importance,
owing to its interaction with the gut microbiota. Moreover, a
major variable in immune responses is represented by age, over-
arching the 9 months of intra-uterine life till the extreme ages
(centenarians).
Accordingly, our hypothesis of liquid self suggests that the
immunological self can change and be modulated by the global
immunological experience of individuals, i.e., by what we have
suggested to call “immunological biography.” The concept of
“immunological biography” synthesizes the individual immuno-
logical history, and has the capacity to take into account both the
qualitative as well as the quantitative and the temporal aspects of
the immunological stimuli that each of us – as an accumulator and
elaborator of antigenic stimuli (42) – is exposed to in our lifelong
history (Table 1).
Indeed, immunity and immune mechanisms emerge (and
evolve at the individual as well as the population level) in parallel
with physiological processes such as nutrition and aging, which
can be considered integral component of “normal” physiology.
A variety of data in the literature suggest that early immuno-
logical stimuli in utero and during early infancy (40, 187), as
well all the other stimuli impinging on the IS lifelong (includ-
ing all the subclinical and persistent infections) can re-direct the
IS toward different functional capabilities, thus predisposing the
single individuals to different diseases, including those age-related.
Thus, our hypothesis of liquid self represents an extension
of the danger/damage theory being focused on the responding
hosts and their spectrum. We surmise that our hypothesis com-
plements the danger/damage theory by adding a temporal and
spatial dimension, which until now remained neglected and not
properly conceptualized (25).
Another set of phenomena such as para-flammation (188),
meta-flammation (189), and inflammaging (190) can be eas-
ily integrated in the “liquid self” hypothesis. The latter would
recapitulate and represent the (interdisciplinary) point of con-
vergence of such types of sterile inflammation. In particular, the
Table 1 | Central tenets of the liquid self hypothesis.
• The immunological self is dynamic, because it varies continuously depend-
ing on the sum of host’s immunological experiences and ecological
context
• Time, i.e., evolutionary (population) and individual (intra-uterine, post-natal,
adult, and extreme age) history, and environmental related factors (geo-
graphical location, nutrition, and lifestyle), something that we collectively
name “immunological biography,” mold the immune identity, changing
what the immune system will react to
• The immunological self is continuous, and not simply binary (i.e., self/non-
self), and it reconfigures along a continuum of states
• The sum of these characteristics (dynamicity, timing, continuity) shapes
the self in a liquid fashion
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FIGURE 1 |Waddington landscape of self/non-self.The immunological fate
of a molecule or a molecular motif is not firmly fixed. Here this process is
depicted in the context of the epigenetic landscape proposed by C.
Waddington in 1940. A given molecule X “differentiates” into various
“immunological profiles” (with more or less immunogenicity), like a ball
rolling down the slope of a valley. Immunological experiences during lifetime
push the molecule up and down the slopes and valleys, and, according to age,
geography, and context (valleys, bifurcations, attractors), it can be perceived
by the immune system as a strong, weak or non-antigen, a danger signal, an
allergene, etc, i.e., showing different and changing degrees of immuno-
genicity all through the individual’s course of life. Consequently, what today
could elicit an immunogenic response, tomorrow would not. Figure modified
from Ref. (192), originally presented in Waddington, C. H. Organisers &
genes. 1940, Cambridge: Cambridge University Press.
low-grade systemic inflamed aging phenotype (inflammaging) is
maintained by cell autonomous mechanisms (the aged micro- and
macro-environment) and can propagate from cells to cells and
from organs to organs, so that local and systemic inflammatory
stimuli sustain and reinforce each other in a complex circuitry.
Similar phenomena are well known in the cancer field where
the propagation of damaged DNA, DNA damage response, and
inflammation to bystander cells has been conceptualized as
para-flammation (191).
Finally, our liquid self hypothesis allows to arrange the recent
discontinuity theory in a wider, systemic framework (48) and
offers a variety of testable predictions. Along these lines, to con-
sider a single, defined molecule self or non-self, without consid-
ering its complex context (responding host), can be misleading.
We predict that a given molecule could indeed be “seen” by the
IS like autologous, antigen, allergene, auto-antigen depending on
the “immunological landscape” carved by specific selective pres-
sure acting on the individual’s history. Waddington advanced the
“epigenetic landscape” during the 40s to visualize the various
developmental pathways a cell might take toward differentiation
(192). Similarly, the immunological landscape could offer a vivid
representation of how fluctuating environmental force during life-
time may alter the evolutionarily fixed genetic response to an
immune stimulus (193) (Figure 1). Furthermore, both the epi-
genetic and immunological landscape stress the dynamic view
of ontogenetic (biographical) selective pressure represented by
multidimensional aspects of time, space, and context (valleys,
bifurcations, attractors).
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